Taeda Yoshinori, Ariga Naohiro, Okamura Kayoko, Takei Naoko, Komeno Takuya, Ueki Hamaiti, Ohtani Haruo
Departments of Surgery, National Hospital Organization, Japan.
Departments of Hematology, National Hospital Organization, Japan.
Breast Cancer. 2006;13(3):322-327. doi: 10.2325/jbcs.13.322.
Primary breast lymphoma, particularly primary mucosa-associated lymphoid tissue (MALT) lymphoma, is a rare disease. We report here a case of a MALT lymphoma of the breast with high-grade transformation. An 84-year-old woman presented with a Pagetoid mass in her right breast. After a clinical diagnosis of breast cancer, T2N1M0, stage II B, she underwent mastectomy with axillary lymph node dissection. She had no history of autoimmune disease such as Hashimoto thyroiditis or Sjögren disease. Pathologically the tumor tissue was composed of small to large lymphoid cells. The large cells contained a considerable number of centroblasts, forming a sheet-like proliferation centrally. Among the small cells many small cleaved cells were present, which were more predominant in the peripheral areas. Immunohistochemistry revealed that these cells were positive for CD20 and CD79a. The tumor cells infiltrated the ductular epithelial cells, distorting the duct structures, to form lymphoepithelial lesions. Immunohistochemistry for cytokeratin and CD20 was helpful for identification. No germinal centers were formed. MALT lymphoma with high-grade transformation was diagnosed. Rituximab (anti-CD20 antibody) was prescribed as systemic treatment without chemotherapy or irradiation. After 18 months, no tumor recurrence was observed. We emphasize the importance of lymphoepithelial lesions for the diagnosis of MALT lymphoma of the breast.
原发性乳腺淋巴瘤,尤其是原发性黏膜相关淋巴组织(MALT)淋巴瘤,是一种罕见疾病。我们在此报告一例发生高级别转化的乳腺MALT淋巴瘤病例。一名84岁女性因右乳出现派杰样肿物就诊。临床诊断为乳腺癌,T2N1M0,II B期,她接受了乳房切除术及腋窝淋巴结清扫术。她无自身免疫性疾病病史,如桥本甲状腺炎或干燥综合征。病理检查显示肿瘤组织由小至大的淋巴细胞组成。大细胞中含有相当数量的中心母细胞,在中央形成片状增殖。在小细胞中存在许多小核裂细胞,在外周区域更为多见。免疫组化显示这些细胞CD20和CD79a呈阳性。肿瘤细胞浸润导管上皮细胞,使导管结构变形,形成淋巴上皮病变。细胞角蛋白和CD20免疫组化有助于识别。未形成生发中心。诊断为发生高级别转化的MALT淋巴瘤。给予利妥昔单抗(抗CD20抗体)进行全身治疗,未进行化疗或放疗。18个月后,未观察到肿瘤复发。我们强调淋巴上皮病变对乳腺MALT淋巴瘤诊断的重要性。